Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stewart B Harris

Showing results (21-30 of 163) with videos related to

Pageof 17
Sort By:
Diabetes Technology & Therapeutics|February 19, 2025
FRONTIER-FreeStyle Libre System Use in Ontario Among People with Diabetes Mellitus in the IC/ES Database-Evidence from Real-World Practice: Patients Using Intensive InsulinAlexandria Ratzki-Leewing, Stewart B Harris, Rémi Rabasa-Lhoret, et al.
Diabetes, Obesity & Metabolism|March 21, 2025
FRONTIER: FReeStyle Libre system use in Ontario among people with diabetes in the IC/ES database-Evidence from real-world practice: Patients on basal insulin, glucagon-like peptide 1 receptor agonist or oral therapiesAlexandria Ratzki-Leewing, Stewart B Harris, Rémi Rabasa-Lhoret, et al.
Family Practice|March 4, 2009
Treatment satisfaction of diabetic patients: what are the contributing factors?Aya Biderman, Enav Noff, Stewart B Harris, et al.
Diabetes Research and Clinical Practice|May 14, 2005
Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study)Stewart B Harris, Jean-Marie Ekoé, Yola Zdanowicz, et al.
Diabetes Research and Clinical Practice|September 5, 2008
Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive reviewMariam Naqshbandi, Stewart B Harris, James G Esler, et al.
Diabetes Care|June 29, 2011
Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose toleranceRavi Retnakaran, Ying Qi, Stewart B Harris, et al.
Diabetes Care|November 25, 2003
Adiponectin in a native Canadian population experiencing rapid epidemiological transitionAnthony J G Hanley, Philip W Connelly, Stewart B Harris, et al.
Diabetes Care|August 3, 2017
When Insulin Therapy Fails: The Impact of SGLT2 Inhibitors in Patients With Type 2 DiabetesStewart B Harris, Selam Mequanint, Kristina Miller, et al.
Journal of Evaluation in Clinical Practice|January 26, 2016
Case study of evaluations that go beyond clinical outcomes to assess quality improvement diabetes programmes using the Diabetes Evaluation Framework for Innovative National Evaluations (DEFINE)Jann Paquette-Warren, Stewart B Harris, Mariam Naqshbandi Hayward, et al.
International Journal of Environmental Research and Public Health|July 13, 2010
The geography of diabetes in London, Canada: the need for local level policy for prevention and managementJordan W Tompkins, Isaac N Luginaah, Gillian L Booth, et al.
Pageof 17

Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
Diabetes Technology & Therapeutics|February 19, 2025
FRONTIER-FreeStyle Libre System Use in Ontario Among People with Diabetes Mellitus in the IC/ES Database-Evidence from Real-World Practice: Patients Using Intensive InsulinAlexandria Ratzki-Leewing, Stewart B Harris, Rémi Rabasa-Lhoret, et al.
Diabetes, Obesity & Metabolism|March 21, 2025
FRONTIER: FReeStyle Libre system use in Ontario among people with diabetes in the IC/ES database-Evidence from real-world practice: Patients on basal insulin, glucagon-like peptide 1 receptor agonist or oral therapiesAlexandria Ratzki-Leewing, Stewart B Harris, Rémi Rabasa-Lhoret, et al.
Family Practice|March 4, 2009
Treatment satisfaction of diabetic patients: what are the contributing factors?Aya Biderman, Enav Noff, Stewart B Harris, et al.
Diabetes Research and Clinical Practice|May 14, 2005
Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study)Stewart B Harris, Jean-Marie Ekoé, Yola Zdanowicz, et al.
Diabetes Research and Clinical Practice|September 5, 2008
Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive reviewMariam Naqshbandi, Stewart B Harris, James G Esler, et al.
Diabetes Care|June 29, 2011
Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose toleranceRavi Retnakaran, Ying Qi, Stewart B Harris, et al.
Diabetes Care|November 25, 2003
Adiponectin in a native Canadian population experiencing rapid epidemiological transitionAnthony J G Hanley, Philip W Connelly, Stewart B Harris, et al.
Diabetes Care|August 3, 2017
When Insulin Therapy Fails: The Impact of SGLT2 Inhibitors in Patients With Type 2 DiabetesStewart B Harris, Selam Mequanint, Kristina Miller, et al.
Journal of Evaluation in Clinical Practice|January 26, 2016
Case study of evaluations that go beyond clinical outcomes to assess quality improvement diabetes programmes using the Diabetes Evaluation Framework for Innovative National Evaluations (DEFINE)Jann Paquette-Warren, Stewart B Harris, Mariam Naqshbandi Hayward, et al.
International Journal of Environmental Research and Public Health|July 13, 2010
The geography of diabetes in London, Canada: the need for local level policy for prevention and managementJordan W Tompkins, Isaac N Luginaah, Gillian L Booth, et al.
Pageof 17